Thales, a cryptographic solutions provider, and SureClinical, a provider of cloud-based content management application software and services for health sciences, announced this month that SureClinical is using Thales' nShield hardware security modules (HSMs) to secure its cloud-based digital signing solution.

Thales HSMs are used to secure the built-in Adobe document signing/verification technology and provide a strong anchor of trust in the digital signature process. It is the first cloud-based digital signing solution to win Food and Drug Administration and European Commission compliance validation for use in pharmaceutical trials.

As a result, pharmaceutical and healthcare companies can now conduct clinical trials faster and more cost-efficiently, accelerating speed to market, without compromising security. SureClinical allows drug companies to eliminate paper, share documents easily, automate document handling, and capture regulatory-compliant signatures on hand-held devices.